tiprankstipranks
Smith & Nephew Snats (SNN)
NYSE:SNN

Smith & Nephew Snats Stock Analysis & Ratings

SNN Stock Chart & Stats

Day’s Range$31.9 - $32.39
52-Week Range$29.40 - $44.47
Previous Close$31.72
Volume653.50K
Average Volume (3M)839.70K
Market Cap$14.09B
P/E Ratio26.9
Beta0.62
Next EarningsJul 28, 2022
Dividend Yield0.73 (2.32%)
1Y Price TargetN/A
Smart Score2
EPS (TTM)1.20


Smith & Nephew Snats News

Currently, no data available
Please return soon. This page is being updated.

---

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

SNN FAQ

What was Smith & Nephew Snats’s price range in the past 12 months?
Smith & Nephew Snats lowest stock price was $29.40 and its highest was $44.47 in the past 12 months.
    What is Smith & Nephew Snats’s market cap?
    Smith & Nephew Snats’s market cap is $14.09B.
      What is Smith & Nephew Snats’s price target?
      Currently, no data Available
      What do analysts say about Smith & Nephew Snats?
      Smith & Nephew Snats’s analyst rating consensus is a ‘Hold. This is based on the ratings of 1 Wall Streets Analysts.
        When is Smith & Nephew Snats’s upcoming earnings report date?
        Smith & Nephew Snats’s upcoming earnings report date is Jul 28, 2022 which is in 71 days.
          How were Smith & Nephew Snats’s earnings last quarter?
          Smith & Nephew Snats released its earnings results on Feb 22, 2022. The company reported $0.8 earnings per share for the quarter, missing the consensus estimate of $0.87 by -$0.07.
            Is Smith & Nephew Snats overvalued?
            According to Wall Street analysts Smith & Nephew Snats’s price is currently Overvalued.
              Does Smith & Nephew Snats pay dividends?
              Smith & Nephew Snats pays a Semiannually dividend of $0.45 which represents an annual dividend yield of 2.32%. Smith & Nephew Snats’s last Semiannually dividend payment was on May 11, 2022. Smith & Nephew Snats’s upcoming ex-dividend date is Mar 31, 2022
                What is Smith & Nephew Snats’s EPS estimate?
                Smith & Nephew Snats’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Smith & Nephew Snats have?
                Smith & Nephew Snats has 436,190,000 shares outstanding.
                  What happened to Smith & Nephew Snats’s price movement after its last earnings report?
                  Smith & Nephew Snats reported an EPS of $0.8 in its last earnings report, missing expectations of $0.87. Following the earnings report the stock price went up 5.943%.
                    Which hedge fund is a major shareholder of Smith & Nephew Snats?
                    Among the largest hedge funds holding Smith & Nephew Snats’s share is Bridgewater Associates, LP. It holds Smith & Nephew Snats’s shares valued at 4M.

                      ---

                      Smith & Nephew Snats Stock Analysis

                      Smart Score
                      2
                      Underperform
                      1
                      2
                      3
                      4
                      5
                      6
                      7
                      8
                      9
                      10
                      Price Target
                      No data currently available
                      The Smith & Nephew Snats stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Smith & Nephew Snats

                      Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced wound care, wound bioactives, and wound devices. It operates through the United Kingdom, United States of America, and Other geographical segments. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Stryker
                      Johnson & Johnson
                      Zimmer Biomet Holdings
                      Conmed
                      ConforMIS

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis